JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elimadi, A.
Right arrow Articles by Tillement, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elimadi, A.
Right arrow Articles by Tillement, J.-P.

Vol. 286, Issue 1, 23-28, July 1998

Trimetazidine Counteracts the Hepatic Injury Associated with Ischemia-Reperfusion by Preserving Mitochondrial Function1

Aziz Elimadi, Abdellatif Settaf, Didier Morin , Rosa Sapena, Fatima Lamchouri, Yahia Cherrah and Jean-Paul Tillement

Département de Pharmacologie (A.E., D.M., R.S., J.P.T.), CNRS (D.M.), IM3, Faculté de Médecine de Paris XII, France; Département de Pharmacologie (A.S., F.L., Y.C.), Faculté de Médecine et de Pharmacie de Rabat, Morocco

Recent studies suggest a crucial role played by mitochondria in the pathogenesis of ischemia-reperfusion injury. This study was conducted to clarify the role of trimetazidine, a cellular anti-ischemic agent, on mitochondria isolated from rat liver subjected to 120-min normothermic ischemia followed by 30-min reperfusion. Rats were divided into groups, pretreated with different doses of trimetazidine (5, 10 and 20 mg/kg/day) or saline and subjected to the ischemia-reperfusion process; another group served as the sham-operated controls. Alanine aminotransferase and aspartate aminotransferase activities and hepatocyte ATP content, bile flow and mitochondrial functions were assessed. Ischemia-reperfusion caused membrane leakage from hepatocytes and a decrease in ATP content and in bile flow. These effects were well correlated with alterations in mitochondrial function, namely, decrease in ATP synthesis, NAD(P)H level and mitochondrial membrane potential and generation of mitochondrial permeability transition. The pretreatment of rats with trimetazidine prevented these ischemia-reperfusion deleterious effects at both the cellular and mitochondrial level in a dose-dependent manner. It is concluded that trimetazidine at an optimal dosage of 10 mg/kg/day protects mitochondria against the deleterious effects of ischemia-reperfusion. This protective effect appears to be the key factor through which this drug exerts its cytoprotective activity.

0022-3565/98/2861-0023$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 HeartHome page
A. O Onbasili, Y. Yeniceriglu, P. Agaoglu, A. Karul, T. Tekten, H. Akar, and G. Discigil
Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
Heart, June 1, 2007; 93(6): 698 - 702.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
C. Jayle, F. Favreau, K. Zhang, C. Doucet, J. M. Goujon, W. Hebrard, M. Carretier, M. Eugene, G. Mauco, J. P. Tillement, et al.
Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1082 - F1093.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev, January 1, 2007; 87(1): 99 - 163.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
I. Inci, A. Dutly, V. Rousson, A. Boehler, and W. Weder
Trimetazidine protects the energy status after ischemia and reduces reperfusion injury in a rat single lung transplant model
J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1155 - 1161.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Hauet, J. M. Goujon, and A. Vandewalle
To what extent can limiting cold ischaemia/reperfusion injury prevent delayed graft function?
Nephrol. Dial. Transplant., October 1, 2001; 16(10): 1982 - 1985.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Elimadi and P. S. Haddad
Cold preservation-warm reoxygenation increases hepatocyte steady-state Ca2+ and response to Ca2+-mobilizing agonist
Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G809 - G815.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Nagahara, M. Ikekita, and T. Shinomiya
Immunosuppressant FTY720 Induces Apoptosis by Direct Induction of Permeability Transition and Release of Cytochrome c from Mitochondria
J. Immunol., September 15, 2000; 165(6): 3250 - 3259.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. Hauet, H. Baumert, I. B. Amor, H. Gibelin, C. Tallineau, M. Eugene, J. P. Tillement, and M. Carretier
Pharmacological Limitation of Damage to Renal Medulla after Cold Storage and Transplantation by Trimetazidine
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 254 - 260.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
T. HAUET, J.-M. GOUJON, A. VANDEWALLE, H. BAUMERT, L. LACOSTE, J.-P. TILLEMENT, M. EUGENE, and M. CARRETIER
Trimetazidine Reduces Renal Dysfunction by Limiting the Cold Ischemia/Reperfusion Injury in Autotransplanted Pig Kidneys
J. Am. Soc. Nephrol., January 1, 2000; 11(1): 138 - 148.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
P. Marchetti, N. Zamzami, B. Joseph, S. Schraen-Maschke, C. Mereau-Richard, P. Costantini, D. Metivier, S. A. Susin, G. Kroemer, and P. Formstecher
The Novel Retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene Carboxylic Acid Can Trigger Apoptosis through a Mitochondrial Pathway Independent of the Nucleus
Cancer Res., December 1, 1999; 59(24): 6257 - 6266.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.